The global Active Pharmaceutical Ingredients (API) market is undergoing a seismic shift, driven by the increasing prevalence of chronic diseases, a burgeoning geriatric population, and the rapid expansion of the biopharmaceutical sector. As of 2024, the API market is valued at hundreds of billions of dollars, with a projected compound annual growth rate (CAGR) that reflects the world's unrelenting need for accessible and effective medicine. In this complex ecosystem, the demand for high-quality, GMP-certified synthetic and biological APIs has never been higher.
Industrial trends are moving toward "Green Chemistry" and specialized manufacturing techniques like continuous flow processing. Global procurement teams from the US, EU, and emerging markets are increasingly looking for partners who can offer not just raw materials, but technical expertise, regulatory support, and supply chain resilience. This is where China’s manufacturing prowess becomes indispensable.
Technological integration, such as AI-driven drug discovery and automated synthesis, is redefining how factories operate. Our facility in Hangzhou stays at the forefront of these trends, ensuring that every batch of Enrofloxacin 99% Purity or other synthetic drugs meets the rigorous standards of international pharmacopoeias.
Procurement professionals today prioritize "Total Quality Management." They require manufacturers who understand the nuances of DMF (Drug Master File) submissions and possess a deep understanding of the global regulatory environment (FDA, EMA, NMPA).
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants.
Long-term trade relations with India, Southeast Asia, South Korea, and Japan, providing full-process market and sales services.
We provide factory quality management system certification consulting and product registration services for global compliance.
Drugs and intermediates are widely used in critical industrial and medical sectors. Our expertise covers pharmaceutical intermediates, industrial raw materials, and chemical substances essential for the production of advanced intermediates.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
China has solidified its position as the "Pharmacy of the World." The country’s sophisticated infrastructure, coupled with a highly skilled workforce and government support for high-tech biochemistry, allows for cost-effective yet high-quality production. Global enterprises seek Chinese manufacturers to mitigate supply chain risks and leverage the competitive pricing of raw materials like Gentamicin Sulfate GMP Grade.
API application varies significantly across regions. In Southeast Asia, there is a high demand for veterinary APIs to support the massive aquaculture and poultry industries. In contrast, European markets focus on high-purity intermediates for specialized human medicine. Hangzhou Jeci Biochem adapts its catalog to these localized needs, offering everything from anti-parasitic solutions to complex synthetic powders.
SJ medical
